Nanalysis Announces Board Transition and Appointment of Three New Directors

CALGARY, AB, May 1, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, is pleased to announce the appointment of Jonathan Ladd, Werner Maas, and Steve Feick to its Board of Directors effective May 1, 2026. Mr. Ladd is an experienced technology executive and former Chief Executive Officer of NovAtel Inc., a Nasdaq-listed GPS technology company acquired by Hexagon AB.